NASDAQ:MURA Mural Oncology (MURA) Stock Price, News & Analysis → Nvidia CEO Says It Will Be “the Next Revolution” Beyond AI (From Banyan Hill Publishing) (Ad) Free MURA Stock Alerts $3.78 +0.08 (+2.16%) (As of 05/1/2024 ET) Add Compare Share Share Today's Range$3.68▼$3.8650-Day Range$3.53▼$5.4652-Week Range$3.23▼$17.00Volume111,912 shsAverage Volume255,330 shsMarket Capitalization$63.96 millionP/E RatioN/ADividend YieldN/APrice Target$13.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Get Mural Oncology alerts: Email Address Mural Oncology MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside243.9% Upside$13.00 Price TargetShort InterestBearish8.08% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.23Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($10.63) to ($4.81) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.92 out of 5 starsMedical Sector616th out of 927 stocksPharmaceutical Preparations Industry270th out of 420 stocks 3.5 Analyst's Opinion Consensus RatingMural Oncology has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageMural Oncology has only been the subject of 1 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted8.08% of the float of Mural Oncology has been sold short.Short Interest Ratio / Days to CoverMural Oncology has a short interest ratio ("days to cover") of 5.3.Change versus previous monthShort interest in Mural Oncology has recently increased by 3.91%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldMural Oncology does not currently pay a dividend.Dividend GrowthMural Oncology does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MURA. Previous Next 1.8 News and Social Media Coverage News SentimentMural Oncology has a news sentiment score of 0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.35 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Mural Oncology this week, compared to 6 articles on an average week.Search InterestOnly 5 people have searched for MURA on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.MarketBeat Follows5 people have added Mural Oncology to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Mural Oncology insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.06% of the stock of Mural Oncology is held by insiders.Percentage Held by Institutions80.21% of the stock of Mural Oncology is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Mural Oncology are expected to grow in the coming year, from ($10.63) to ($4.81) per share.Price to Book Value per Share RatioMural Oncology has a P/B Ratio of 0.24. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. About Mural Oncology Stock (NASDAQ:MURA)Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops nemvaleukin to treat cutaneous melanoma and advanced solid tumors. The company is also developing engineered interleukin-18 and tumor-targeted interleukin-12 programs. Mural Oncology plc was incorporated in 2017 and is based in Dublin, Ireland.Read More MURA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MURA Stock News HeadlinesApril 30, 2024 | msn.comTeen artist captures essence of Brighton's Mill Pond with new mural at downtown businessApril 26, 2024 | msn.comNFL draft hits Detroit neighborhoods, not just downtown | OpinionMay 1, 2024 | Porter & Company (Ad)The biggest energy story ever? Discover why I’m calling this one of the biggest developments in the global energy market since the shale revolution… why everything you’ve ever been told about Trump’s environmental record is a lie…April 26, 2024 | americanbankingnews.comMural Oncology (NASDAQ:MURA) Stock Price Down 1.9%April 25, 2024 | msn.comButterfly mural unveiled in Philadelphia's Old City neighborhood ahead of 20th annual Sandy Sprint 5K run/walkApril 24, 2024 | globenewswire.comMural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual MeetingApril 23, 2024 | uk.news.yahoo.com‘My brother died after cancer battle - he wouldn’t believe how much we fundraised’April 22, 2024 | msn.comInside the RUH's new £50m Dyson Cancer CentreMay 1, 2024 | Porter & Company (Ad)The biggest energy story ever? Discover why I’m calling this one of the biggest developments in the global energy market since the shale revolution… why everything you’ve ever been told about Trump’s environmental record is a lie…April 19, 2024 | msn.comCommunity mural painting event happening next monthApril 19, 2024 | nytimes.comThe House Is Set to Approve Ukraine Aid This WeekendApril 19, 2024 | msn.comWater Curia, a tribute to Bill Stowe and water quality, coming to Water Works ParkApril 19, 2024 | msn.comAfter squatters took over Gordon Ramsay's London pub, celebrity chef fights to take it backApril 19, 2024 | msn.comVideo shows Brooklyn twins stabbing suspect was acting in self-defense, attorney saysApril 16, 2024 | msn.comQC artist creates colorful nature oasis atop new YWCAApril 16, 2024 | msn.comMystery QR Code In Chicago Mural Leads To Taylor Swift And Tortured Poets Sending Fans Into A FrenzyApril 16, 2024 | nytimes.comFarewell, and Thanks, to a Man Who Kept Kids SafeApril 12, 2024 | uk.news.yahoo.comNew mural by renowned graffiti artist unveiled at Glasgow hospiceApril 11, 2024 | ca.style.yahoo.com10 Celebrities Who Got Their Start on ‘The Mickey Mouse Club’April 9, 2024 | globenewswire.comMural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual MeetingApril 7, 2024 | msn.comBayfair motorway tunnel mural transformationApril 5, 2024 | ca.news.yahoo.comArtist paints mural ahead of solar eclipseApril 4, 2024 | markets.businessinsider.comMural Oncology’s Buy Rating: Financial Stability and Promising Drug Candidate Propel Growth ProspectsApril 4, 2024 | globenewswire.comMural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 4, 2024 | uk.news.yahoo.comNavalny Mural in Buenos Aires Draws Complaints, Police PresenceApril 2, 2024 | msn.comKate Middleton ‘forced to reveal cancer’ after medical records were leakedApril 2, 2024 | msn.comKate Middleton ‘forced to reveal cancer’ after threat of medical records leakingSee More Headlines Receive MURA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mural Oncology and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/26/2024Today5/01/2024Next Earnings (Estimated)6/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:MURA Previous SymbolNASDAQ:MURA CUSIPN/A CIK1971543 Webwww.muraloncology.com Phone353-1-905-8020FaxN/AEmployees117Year FoundedN/APrice Target and Rating Average Stock Price Target$13.00 High Stock Price Target$13.00 Low Stock Price Target$13.00 Potential Upside/Downside+243.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio9.56 Quick Ratio9.56 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$15.81 per share Price / Book0.24Miscellaneous Outstanding Shares16,920,000Free Float16,913,000Market Cap$63.96 million OptionableNo Data BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMs. Caroline J. Loew Ph.D. (Age 53)President, CEO & Director Comp: $303.29kMr. Adam D. Cutler B.A. (Age 49)CFO, Principal Financial Officer & Principal Accounting Officer Comp: $496.65kDr. Vicki L. Goodman M.D. (Age 53)Chief Medical Officer Comp: $578.34kMs. Maiken Keson-Brookes (Age 51)Chief Legal Officer Mr. Justin LevineHead of Human Resources & VP of Human ResourcesKey CompetitorsCelularityNASDAQ:CELUCalciMedicaNASDAQ:CALCKronos BioNASDAQ:KRONLantern PharmaNASDAQ:LTRNKezar Life SciencesNASDAQ:KZRView All Competitors MURA Stock Analysis - Frequently Asked Questions Should I buy or sell Mural Oncology stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Mural Oncology in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MURA shares. View MURA analyst ratings or view top-rated stocks. What is Mural Oncology's stock price target for 2024? 1 analysts have issued 1-year price targets for Mural Oncology's stock. Their MURA share price targets range from $13.00 to $13.00. On average, they expect the company's share price to reach $13.00 in the next twelve months. This suggests a possible upside of 243.9% from the stock's current price. View analysts price targets for MURA or view top-rated stocks among Wall Street analysts. How have MURA shares performed in 2024? Mural Oncology's stock was trading at $5.92 at the start of the year. Since then, MURA stock has decreased by 36.1% and is now trading at $3.78. View the best growth stocks for 2024 here. When is Mural Oncology's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 25th 2024. View our MURA earnings forecast. How were Mural Oncology's earnings last quarter? Mural Oncology plc (NASDAQ:MURA) posted its quarterly earnings data on Tuesday, March, 26th. The company reported ($3.57) earnings per share for the quarter. What ETF holds Mural Oncology's stock? Horizon Kinetics Medical ETF holds 2,304 shares of MURA stock, representing 0.05% of its portfolio. How do I buy shares of Mural Oncology? Shares of MURA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MURA) was last updated on 5/1/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget Nvidia. This is the future of AIPorter & CompanyBiden out June 13; Kamala won’t replace him?Paradigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing4 coins to be the “Next Bitcoin”True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mural Oncology plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
